Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Americas
Addiction treatment drug producer Indivior has obtained a temporary restraining order against Indian generic maker Dr Reddy’s, blocking the company from launching a generic version of Suboxone (buprenorphine and naloxone) Film.   18 June 2018
Americas
US Senator Orrin Hatch has proposed an amendment to the Hatch-Waxman Act to “restore the careful balance” the act struck to incentivise generic drug development.   15 June 2018
Asia
US-based biopharmaceutical company Sage Therapeutics and Japan-based pharmaceutical corporation Shionogi have entered into a strategic collaboration to develop an antidepressant drug.   15 June 2018
Americas
The Patent Trial and Appeal Board has now rejected challenges to six patents owned by Gilead covering the company’s hepatitis C medicines.   14 June 2018
Big Pharma
The EU General Court today ruled on a pharmaceutical trademark dispute over the names ‘Emcur’ and ‘Emcure’, finding similarity for some goods and services but not others.   14 June 2018
Americas
Clinical technology company Medidata has bought Shyft Analytics, a cloud data analytics platform, for $195 million.   13 June 2018
Americas
China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.   13 June 2018
Americas
An Indiana district court did not abuse its discretion in denying attorneys’ fees to medical device company Cook Medical, the US Court of Appeals for the Federal Circuit said yesterday in a precedential decision.   12 June 2018
Americas
Drug makers Takeda and Lundbeck have filed a patent infringement lawsuit over anti-depressant medication Trintellix (vortioxetine hydrobromide), less than a month after launching similar claims.   12 June 2018
Americas
The US Federal Trade Commission has filed an amicus brief urging a district court to reject Takeda’s claim that its patent infringement lawsuit brought under the Hatch-Waxman Act cannot be a sham.   11 June 2018